Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
      • 1-Minute Consult
      • Commentary
      • Current Drug Therapy
      • Editorial
      • Guidelines to Practice
      • Interpreting Key Trials
      • Letter to the Editor
      • Review
      • Smart Testing
      • Symptoms to Diagnosis
      • The Clinical Picture
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
1-Minute Consult

Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?

Suneela Vegunta, MD and Margaret E. Long, MD
Cleveland Clinic Journal of Medicine September 2020, 87 (9) 541-544; DOI: https://doi.org/10.3949/ccjm.87a.19145
Suneela Vegunta
Division of Women’s Health Internal Medicine, Mayo Clinic, Scottsdale, AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vegunta.suneela@mayo.edu
Margaret E. Long
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

REFERENCES

  1. ↵
    1. Moscicki AB,
    2. Darragh TM,
    3. Berry-Lawhorn JM, et al
    . Screening for anal cancer in women. J Low Genit Tract Dis 2015; 19(3 suppl 1):S27–S42. doi:10.1097/LGT.0000000000000117
    OpenUrlCrossRefPubMed
    1. Myers ER,
    2. McCrory DC,
    3. Nanda K,
    4. Bastian L,
    5. Matchar DB
    . Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151(12):1158–1171. doi:10.1093/oxfordjournals.aje.a010166
    OpenUrlCrossRefPubMed
  2. ↵
    1. Beachler DC,
    2. Kreimer AR,
    3. Schiffman M, et al
    . Multisite HPV16/18 vaccine efficacy against cervical, anal, and oral HPV infection. J Natl Cancer Inst 2015; 108(1):djv302. doi:10.1093/jnci/djv302
    OpenUrlCrossRefPubMed
  3. ↵
    1. Gillison ML,
    2. Chaturvedi AK,
    3. Anderson WF,
    4. Fakhry C
    . Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol 2015;33(29):3235–3242. doi:10.1200/JCO.2015.61.6995
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. National Cancer Institute
    . SEER cancer statistics review (CSR) 1975–2015. https://seer.cancer.gov/archive/csr/1975_2015/. Accessed August 5, 2020.
  5. ↵
    1. Watson M,
    2. Soman A,
    3. Flagg EW, et al
    . Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009–2012. Prev Med 2017; 103:60–65. doi:10.1016/j.ypmed.2017.07.027
    OpenUrlCrossRef
  6. ↵
    1. Hariri S,
    2. Bennett NM,
    3. Niccolai LM, et al
    . Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States—2008–2012. Vaccine 2015;33(13):1608–1613. doi:10.1016/j.vaccine.2015.01.084
    OpenUrlCrossRefPubMed
  7. ↵
    1. Van Dyne EA,
    2. Henley SJ,
    3. Saraiya M,
    4. Thomas CC,
    5. Markowitz LE,
    6. Benard VB
    . Trends in human papillomavirus-associated cancers— United States, 1999–2015. MMWR Morb Mortal Wkly Rep 2018; 67(33):918–924. doi:10.15585/mmwr.mm6733a2
    OpenUrlCrossRef
  8. ↵
    1. National Cancer Institute
    . Cancer stat facts: anal cancer. https://seer.cancer.gov/statfacts/html/anus.html. Accessed August 5, 2020.
  9. ↵
    1. Saleem AM,
    2. Paulus JK,
    3. Shapter AP,
    4. Baxter NN,
    5. Roberts PL,
    6. Ricciardi R
    . Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol 2011;117(3):643–649. doi:10.1097/AOG.0b013e31820bfb16
    OpenUrlCrossRefPubMed
  10. ↵
    1. Hoots BE,
    2. Palefsky JM,
    3. Pimenta JM,
    4. Smith JS
    . Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124(10):2375–2383. doi:10.1002/ijc.24215
    OpenUrlCrossRefPubMed
    1. Alemany L,
    2. Saunier M,
    3. Alvarado-Cabrero I, et al
    . Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 2015;136(1):98–107. doi:10.1002/ijc.28963
    OpenUrlCrossRef
  11. ↵
    1. Morel A,
    2. Neuzillet C,
    3. Wack M, et al
    . Mechanistic signatures of human papillomavirus insertions in anal squamous cell carcinomas. Cancers (Basel) 2019;11(12):1846. doi:10.3390/cancers11121846
    OpenUrlCrossRef
  12. ↵
    1. Perkins RB,
    2. Guido RS,
    3. Castle PE, et al
    . 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24(2):102–131. doi:10.1097/LGT.0000000000000525
    OpenUrlCrossRef
  13. ↵
    1. Moscicki AB,
    2. Flowers L,
    3. Huchko MJ, et al
    . Guidelines for cervical cancer screening in immunosuppressed women without HIV infection. J Low Genit Tract Dis 2019;23(2):87–101. doi:10.1097/LGT.0000000000000468
    OpenUrlCrossRef
  14. ↵
    1. National Cancer Institute
    . Diethylstilbestrol (DES) and cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/desfact-sheet. Accessed August 5, 2020.
  15. ↵
    1. Fokom Domgue J,
    2. Messick C,
    3. Milbourne A, et al
    . Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: results of a pilot study. Gynecol Oncol 2019;153(2):266–270. doi:10.1016/j.ygyno.2019.02.024
    OpenUrlCrossRef
  16. ↵
    1. Eleutério J Jr.,
    2. Cavalcante LR,
    3. Gonçalves AKS,
    4. Eleutério RMN,
    5. Giraldo PC
    . Prevalence of high-risk HPV and atypia in liquid-based cytology of cervical and intra-anal specimens from kidney-transplanted women. Diagn Cytopathol 2019; 47(8):783–787. doi:10.1002/dc.24180
    OpenUrlCrossRef
  17. ↵
    1. Chin-Hong PV,
    2. Palefsky JM
    . Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35(9):1127–1134. doi:10.1086/344057
    OpenUrlCrossRefPubMed
  18. ↵
    1. Parkin DM,
    2. Bray F
    . Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24(suppl 3):S3/11–S3/25. doi:10.1016/j.vaccine.2006.05.111
    OpenUrlCrossRef
  19. ↵
    1. Hillman RJ,
    2. Berry-Lawhorn JM,
    3. Ong JJ, et al
    . International Anal Neoplasia Society guidelines for the practice of digital anal rectal examination. J Low Genit Tract Dis 2019;23(2):138–146. doi:10.1097/LGT.0000000000000458
    OpenUrlCrossRef
  20. ↵
    1. National AIDS Treatment Advocacy Program
    . NYS guidelines recommendations on anal Pap smears. http://www.natap.org/2010/HIV/032510_01.htm. Accessed August 5, 2020.
  21. ↵
    1. Lili E,
    2. Chatzistamatiou K,
    3. Kalpaktsidou-Vakiani A,
    4. Moysiadis T,
    5. Agorastos T
    . Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up. Medicine (Baltimore) 2018; 97(4):e9719. doi:10.1097/MD.0000000000009719
    OpenUrlCrossRef

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Cleveland Clinic Journal of Medicine: 87 (9)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 9
1 Sep 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
Suneela Vegunta, Margaret E. Long
Cleveland Clinic Journal of Medicine Sep 2020, 87 (9) 541-544; DOI: 10.3949/ccjm.87a.19145

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
Suneela Vegunta, Margaret E. Long
Cleveland Clinic Journal of Medicine Sep 2020, 87 (9) 541-544; DOI: 10.3949/ccjm.87a.19145
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • 15 HIGH-RISK HPV GENOTYPES
    • HPV-RELATED CANCERS
    • HPV AND CANCER SCREENING
    • A PRUDENT STRATEGY
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The HPV vaccine: Understanding and addressing barriers to vaccination
  • Google Scholar

More in this TOC Section

  • Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?
  • When is contrast needed for abdominal and pelvic CT?
  • Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Women's Health
  • Preventive Care
  • Oncology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit
  • Advertise Contact

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • Advertisers
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2021 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire